Artimplant: Invitation to Artimplant's Capital Market Day on November 16, 2006.VASTRA FROLUNDA, Sweden -- We invite you to a capital market day where the new CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Hans Ros[c]n will present the Company's strategy, objectives and financial outcome January - September 2006. Place: Grand Hotel, S. Blasieholmshamnen 8, Stockholm, conference room New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of Date: Thursday, November 16, 2006 Time: 2:00 - 4:00 PM Central European Time Central European Time Noun the standard time adopted by Western European countries one hour ahead of Greenwich Mean Time, corresponding to British Summer Time Abbrev: (CET) (GMT (Greenwich Mean Time) See UTC. GMT - Universal Time 1 +1) The presentation will be in English. A live broadcast will be available on Artimplant[acute accent]s website www.artimplant.com Please note that Artimplant's interim report for January - September, 2006 will be distributed with a press release on November 9, 2006 around lunchtime Central European Time (GMT+1) and it will not be presented at any other occasion than the above mentioned capital market day. About Artimplant Artimplant is a biomaterials company focused on solutions to problems in orthopedic, odontological and reconstructive surgery. The Company is engaged in the development, production and marketing of degradable de·grad·a·ble adj. That can be chemically degraded: degradable plastic wastes. de·grad implants designed to restore active lifestyles and improve quality of life. The proprietary technology Artelon[R], a long-term degradable biomaterial, offers new solutions to unmet clinical needs and opens new markets. Artimplant's business model is that of licensing its products and technology to global partners. The Company currently has six licensing agreements and one distribution agreement with three global partners. Artimplant is a public company, listed on the Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries. , O-list. Forward-looking statements This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence ob·so·les·cent adj. 1. Being in the process of passing out of use or usefulness; becoming obsolete. 2. Biology Gradually disappearing; imperfectly or only slightly developed. ; general economic conditions; and other risks detailed from time to time in the Company's filings. Last day of registration November 13, 2006 to Birgitta Niva, birgitta.niva@artimplant.com, tel. +46 (0)31- 746 56 62, fax +46 (0)31 -746 56 60. This information was brought to you by Waymaker http://www.waymaker.net |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion